Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
ClinicalTrials.gov study NCT07092202. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors: A Randomized Controlled Trial
ClinicalTrials.gov study NCT07090070. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ClinicalTrials.gov study NCT06040541. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors
ClinicalTrials.gov study NCT01262963. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
ClinicalTrials.gov study NCT04085315. IPD Sharing: NO. Countries: 1. Publications: 1.
Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
ClinicalTrials.gov study NCT02257424. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
ClinicalTrials.gov study NCT05052372. IPD Sharing: NO. Countries: 1. Publications: 1.
Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc
ClinicalTrials.gov study NCT01955421. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
ClinicalTrials.gov study NCT05415072. IPD Sharing: UNDECIDED. Countries: 7. Publications: 0.
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
ClinicalTrials.gov study NCT04916236. IPD Sharing: NO. Countries: 1. Publications: 2.
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
ClinicalTrials.gov study NCT07287904. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Study of HL-085 in NRAS Mutant Advanced Melanoma
ClinicalTrials.gov study NCT03973151. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)
ClinicalTrials.gov study NCT03932253. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Muta
ClinicalTrials.gov study NCT00893399. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)
ClinicalTrials.gov study NCT05998993. IPD Sharing: YES. Countries: 1. Publications: 30.
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
ClinicalTrials.gov study NCT06917079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis
ClinicalTrials.gov study NCT04944069. IPD Sharing: NO. Countries: 1. Publications: 19.
Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01951690. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379
ClinicalTrials.gov study NCT02456701. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
ClinicalTrials.gov study NCT01311947. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.